NEUP (Neuphoria Therapeutics) Cyclically Adjusted Book per Share: $2.10 (As of Mar. 2026)


NEUP Neuphoria Therapeutics Inc NEUP
32 GF Score
Price $4.40
! 1 Warning Sign
View Full Analysis

What is Neuphoria Therapeutics Cyclically Adjusted Book per Share?

Neuphoria Therapeutics NEUP -2.87% 32 Cyclically Adjusted Book per Share is $2.10 as of Mar. 2026. GuruFocus rates NEUP with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Neuphoria Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was $5.472. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.10 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Neuphoria Therapeutics's average Cyclically Adjusted Book Growth Rate was 96.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 211.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 55.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Neuphoria Therapeutics was 211.40% per year. The lowest was -10.60% per year. And the median was -5.00% per year.

As of today (2026-06-30), Neuphoria Therapeutics's current stock price is $4.40. Neuphoria Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $2.10. Neuphoria Therapeutics's Cyclically Adjusted PB Ratio of today is 2.10.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Neuphoria Therapeutics was 13.00. The lowest was 1.99. And the median was 4.68.


Neuphoria Therapeutics  (NAS:NEUP) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Neuphoria Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.40/2.10
=2.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Neuphoria Therapeutics was 13.00. The lowest was 1.99. And the median was 4.68.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Neuphoria Therapeutics Cyclically Adjusted Book per Share Related Terms


Neuphoria Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Neuphoria Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuphoria Therapeutics Cyclically Adjusted Book per Share Chart

Neuphoria Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.05 0.05 0.04 1.51

Neuphoria Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 1.51 1.68 1.92 2.10

NEUP vs PLRZ, SKYE, IGC: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Neuphoria Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuphoria Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neuphoria Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Neuphoria Therapeutics's Cyclically Adjusted PB Ratio falls into.


NEUP
32GF Score
Neuphoria Therapeutics Inc NEUP
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuphoria Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Neuphoria Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=5.472/330.2130*330.2130
=5.472

Current CPI (Mar. 2026) = 330.2130.

Neuphoria Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.057 241.018 0.078
201609 0.000 241.428 0.000
201612 0.047 241.432 0.064
201703 0.000 243.801 0.000
201706 0.056 244.955 0.075
201709 0.000 246.819 0.000
201712 0.044 246.524 0.059
201803 0.000 249.554 0.000
201806 0.022 251.989 0.029
201809 0.000 252.439 0.000
201812 0.019 251.233 0.025
201903 0.000 254.202 0.000
201906 0.020 256.143 0.026
201909 0.000 256.759 0.000
201912 0.013 256.974 0.017
202003 0.000 258.115 0.000
202006 0.012 257.797 0.015
202009 0.000 260.280 0.000
202012 0.016 260.474 0.020
202103 0.000 264.877 0.000
202106 0.035 271.696 0.043
202109 0.000 274.310 0.000
202112 0.033 278.802 0.039
202203 0.000 287.504 0.000
202206 0.029 296.311 0.032
202209 0.000 296.808 0.000
202212 0.022 296.797 0.024
202303 0.000 301.836 0.000
202306 0.015 305.109 0.016
202309 0.000 307.789 0.000
202312 0.010 306.746 0.011
202403 0.000 312.332 0.000
202406 0.088 314.175 0.092
202409 0.066 315.301 0.069
202412 8.440 315.605 8.831
202503 14.022 319.799 14.479
202506 9.607 322.561 9.835
202509 5.305 324.800 5.393
202512 5.524 324.054 5.629
202603 5.472 330.213 5.472

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $2.10 mean?
Neuphoria Therapeutics (NEUP) has a Cyclically Adjusted Book per Share of $2.10 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Neuphoria Therapeutics and its competitors.
Is Neuphoria Therapeutics' Cyclically Adjusted Book per Share too high?
Neuphoria Therapeutics' current Cyclically Adjusted Book per Share is $2.10. Overall, Neuphoria Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Neuphoria Therapeutics' Cyclically Adjusted Book per Share compare to PLRZ and SKYE?
Neuphoria Therapeutics' Cyclically Adjusted Book per Share of $2.10 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Neuphoria Therapeutics and its competitors. Neuphoria Therapeutics's current Cyclically Adjusted Book per Share is $2.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuphoria Therapeutics stock overvalued right now?
Neuphoria Therapeutics (NEUP) has a current Cyclically Adjusted Book per Share of $2.10. The current Cyclically Adjusted Book per Share is $2.10. Neuphoria Therapeutics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Neuphoria Therapeutics (NEUP), the current Cyclically Adjusted Book per Share is $2.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neuphoria Therapeutics Business Description

Address 100 Summit Drive, Burlington, MA, USA, 01803
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
32GF Score

Get the complete analysis for NEUP

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.40
Price